arrow
M

Maurizio Fava

harvard university medical affiliates
H指数:137
被引数:8.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

193. Efficacy and safety of adjunctive lumateperone 42 mg in major depressive disorder: pooled analysis of demographic and clinical subgroups from Phase 3 randomized placebo-controlled trials

193. 邻甲苯胺 42 mg 添加治疗在重度抑郁症中的疗效和安全性:来自 III 期随机安慰剂对照试验的按人口统计学和临床亚组合并分析

2026-09-090
OAAI
Rationale and Design for the BLOCK-SAH Study (Pterygopalatine Fossa Block as an Opioid-Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage): A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial with a Sequential Parallel Comparison Design
2024-08-132
OAAI
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial

抗抑郁药不完全和非应答者治疗抵抗性抑郁症的比较有效性研究试验 (确定-TRD) 随机临床试验

2024-03-075
OAAI